Healthcare Realty Trust (HR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
30 Jun, 2026Executive summary
New President and CEO, Peter Scott, outlined a strategic plan focused on leasing, portfolio optimization, deleveraging, efficiency, and financial discipline.
The company is a pure-play outpatient medical REIT with $11.8B in gross investments, 587 consolidated properties across 33 states, and 34.3M sq. ft. under management.
As of April 25, 2025, 351.4M shares of common stock were outstanding.
Dividend maintained at $0.31 per share, with future decisions pending clarity on earnings and strategic plan execution.
Leadership transition completed with Peter Scott appointed as President and CEO effective April 15, 2025.
Financial highlights
Normalized FFO per share was $0.39 for Q1 2025, in line with expectations and prior year.
Q1 2025 net loss attributable to common stockholders was $44.9M, or $(0.13) per diluted share, improved from Q4 2024.
Same-store cash NOI growth was 2.3% year-over-year, impacted by higher operating expenses and weather volatility.
Four buildings sold for $28.1M; $38M loan payoff received post-quarter; gross proceeds from asset sales and loan repayment totaled $66M.
Net debt to adjusted EBITDA remained at 6.4x; $1.4B available on revolving credit line.
Outlook and guidance
Reaffirmed full-year normalized FFO per share guidance of $1.56–$1.60 and NAREIT FFO per share $1.44–$1.48.
Expect acceleration in same-store NOI growth and uptick in FFO and FAD per share in Q2.
Sequential occupancy growth anticipated through 2025, with 75–125 basis points of absorption by year-end.
Management expects to fund 2025 dividends from operations and available liquidity.
Guidance reflects assumptions on rental rates, occupancy, interest rates, and expenses; excludes impacts from gains/losses on dispositions and impairments.
Latest events from Healthcare Realty Trust
- Registering 36M shares for resale by noteholders; no proceeds to company; NYSE-listed at $21.53.HR
Registration filing - High-performing outpatient medical REIT with strong growth, liquidity, and sector leadership.HR
Investor presentation - Q2 2026 net loss, strong NOI growth, raised guidance, and major capital market actions.HR
Q2 2026 - Record leasing and 6.9% NOI growth drove raised guidance and $100M in share repurchases.HR
Q1 2026 - Strong NOI growth, high occupancy, and disciplined capital allocation drive sector leadership.HR
Investor presentation - Exceeded 2025 FFO guidance, reduced leverage, and set disciplined 2026 growth targets.HR
Q4 2025 - Leasing strength, asset sales, and raised guidance offset a Q3 net loss and lower rental income.HR
Q3 2025 - Q2 net loss on impairments, but strong leasing and asset sales support 2024 FFO outlook.HR
Q2 2024 - Record leasing, robust FFO growth, and focus on deleveraging set the stage for 2025.HR
Q4 2024